Citations 1
428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)
Lewis, Karl D. , Peris, Ketty , Sekulić, Aleksandar , Stratigos, Alexander , Dunn, Lara , Eroglu, Zeynep , Chang, Anne Lynn S. , Migden, Michael R. , Li, Siyu , Mohan, Kosalai Kal, Coates, Ebony, Bechter, Oliver , Hernandez‐Aya, Leonel F. , Neves, Rogerio I. , Ruiz, E.P. Yanez, Seebach, Frank, Yancopoulos, George D., Lowy, Israel , Bowler, Timothy G., Fury, Matthew G., Okoye, Emmanuel, Baurain, Jean‐François , Hauschild, Axel , Butler, Marcus O. , Licitra, Lisa , Ruiz, Emily, Weinreich, David M.
Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A260.2-A261
